Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment - A Phase I Study

NCT01201018 is registered in ClinicalTrials.gov with Oshadi Drug Administration as lead sponsor.

NCT NCT01201018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01201018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment - A Phase I Study
Lead sponsor
Oshadi Drug Administration
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2011
Completion date
May 31, 2012
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastasis, tumor